在急性髓性白血病的血病学模式与外传播的血管内凝血的并发症
Bernhard Strasser1, Sebastian Mustafa1, Josef Seier1
1Institute of Clinical Chemistry and Laboratory Medicine, Klinikum Wels-Grieskirchen 1, 4600 Wels, Austria.
Diagnostics (Basel, Switzerland)
|February 13, 2025
概括
在急性髓性白血病 (AML) 中,传播性血管内凝血 (DIC) 存在诊断挑战. 这项研究确定了三种不同的AML亚型与DIC,有助于早期诊断和量身定制的治疗,以改善患者的治疗结果.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 病理学 病理学 病理学
背景情况:
- 分布式血管内凝血 (DIC) 复杂化了急性髓性白血病 (AML) 的管理.
- 虽然在急性前列细胞白血病 (APL) 中很常见,但在非APL AML 中的DIC理解程度较低.
- 精确的诊断策略对于管理DIC的AML至关重要.
研究的目的:
- 识别和表征AML与明显的DIC不同的血液病理模式.
- 建立一个框架,为AML与DIC的早期和精确诊断.
- 引导量身定制的治疗方法,以改善DIC的AML患者的治疗结果.
主要方法:
- 对被诊断患有明显DIC的AML患者的分析.
- 进行了形态,免疫类型,细胞遗传和遗传评估.
- DIC诊断使用了国际血栓形成和血液静止学会 (ISTH) 评分系统;根据世卫组织标准分类的AML亚型.
主要成果:
- 出现了三种模式:APL (PML::RARa,FLT3突变,CD34/HLA-DR阴性),AML具有FLT3/NPM1突变 (杯状爆发,正常型),AML具有单细胞分化 (单细胞标记,DNMT3A突变/11q23重新排列).
- 两名患者表现出独特的个人资料,这些模式之外.
- 独特的免疫类型和遗传标记标志着与DIC相关的每个AML亚型.
结论:
- 这项研究定义了AML与明显的DIC的鲜明的血液病理模式.
- 这些模式为早期和准确的诊断提供了基础.
- 识别这些亚型对于优化DIC高风险AML患者的诊断和治疗策略至关重要.
相关概念视频
Disorders of Hemostasis
686
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
686
Extrinsic and Intrinsic Pathways of Hemostasis
4.9K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
4.9K
Introduction to Hemostasis
5.1K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
5.1K
Disorders of Leukocytes
838
Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
838
Coagulation
4.3K
The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
4.3K
Anticoagulant Drugs: Low-Molecular-Weight Heparins
601
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
601


